Prevalence of gastro-intestinal symptoms among COVID-19 patients and the association with disease clinical outcomes

Prevalence of gastro-intestinal symptoms among COVID-19 patients and the association with disease clinical outcomes

Aim: This study examined the various manifestations of COVID-19 in people's gastro-intestinal system and how gastro-intestinal involvement relates to the progression and outcome of the disease. Methodology: A questionnaire survey was used to collect data from 561 COVID-19 patients between Febru...

Full description

Bibliographic Details
Main Authors: Hafez Al-Momani, Iman Aolymat, Muna Almasri, Sameer Alhaj Mahmoud, Safaa Mashal
Format: Article
Language:English
Published: Future Science Ltd 2023-06-01
Series:Future Science OA
Subjects:
clinical outcomes
COVID-19
COVID-19 transmission
gastro-intestinal system
mortality
prevalence
Online Access:https://www.future-science.com/doi/10.2144/fsoa-2023-0040
Description
Summary:Aim: This study examined the various manifestations of COVID-19 in people's gastro-intestinal system and how gastro-intestinal involvement relates to the progression and outcome of the disease. Methodology: A questionnaire survey was used to collect data from 561 COVID-19 patients between February 6 and 6 April 2022. Laboratory data and clinical outcomes were obtained from the patients' medical records. Results: 39.9% of patients presented gastro-intestinal symptoms, mainly loss of appetite, nausea, vomiting and diarrhea. Gastro-intestinal symptoms were not linked to poorer outcomes such as mortality, ICU admission or length of hospital stays. Conclusion: gastro-intestinal symptoms were common among patients and may manifest with respiratory symptoms. We recommended clinicians to watch out for gastro-intestinal symptoms as related to COVID-19 infection.
ISSN:2056-5623

Similar Items